ResearcherJinan UniversityActive in the last 2 years
Jiaxin Luo
Matched on ORCID iD 0009-0004-9579-7477; OpenAlex author ID A5013208204. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 33
2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 5
- Erianin inhibits the proliferation and stemness of pancreatic cancer cells by interacting with MEK1/2. Co-author DOI 10.1016/j.bcp.2025.117046↗
- TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2025.113060↗
- BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. Co-author DOI 10.1002/advs.202306298↗
- LINC01137 facilitates pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis Co-author DOI 10.21203/rs.3.rs-2411868/v1↗
- LINC01137 involvement in pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis Co-author DOI 10.21203/rs.3.rs-1516835/v1↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yizhi Cao · 4 shared papers, 2022–2025 · strength 0.64
- Paper TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113060↗
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Paper LINC01137 facilitates pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis DOI 10.21203/rs.3.rs-2411868/v1↗
- Lingxi Jiang · 3 shared papers, 2022–2025 · strength 0.49
- Paper TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113060↗
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Paper LINC01137 involvement in pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis DOI 10.21203/rs.3.rs-1516835/v1↗
- Lijie Han · 3 shared papers, 2022–2024 · strength 0.43
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Paper LINC01137 facilitates pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis DOI 10.21203/rs.3.rs-2411868/v1↗
- Paper LINC01137 involvement in pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis DOI 10.21203/rs.3.rs-1516835/v1↗
- Chenghong Peng · 3 shared papers, 2022–2024 · strength 0.43
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Paper LINC01137 facilitates pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis DOI 10.21203/rs.3.rs-2411868/v1↗
- Paper LINC01137 involvement in pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis DOI 10.21203/rs.3.rs-1516835/v1↗
- Yongsheng Jiang · 3 shared papers, 2022–2024 · strength 0.43
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Paper LINC01137 facilitates pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis DOI 10.21203/rs.3.rs-2411868/v1↗
- Paper LINC01137 involvement in pancreatic cancer stemness via the miR-7155-5p/KLF12/AKT axis DOI 10.21203/rs.3.rs-1516835/v1↗
- Xiaomei Tang · 2 shared papers, 2024–2025 · strength 0.37
- Meilin Xue · 2 shared papers, 2024–2025 · strength 0.37
- Hao Chen · 2 shared papers, 2023–2024 · strength 0.30
- Jiewei Lin · 2 shared papers, 2022–2023 · strength 0.28
- Zengyu Feng · 2 shared papers, 2022–2023 · strength 0.28
- Kexian Li · 2 shared papers, 2022–2023 · strength 0.28
- Kai Qin · 2 shared papers, 2022–2023 · strength 0.28
- Yiqi Zhu · 1 shared paper, 2025 · strength 0.26
- Lijuan Deng · 1 shared paper, 2025 · strength 0.26
- Kexian Li · 1 shared paper, 2025 · strength 0.21
- Dongjie Chen · 1 shared paper, 2025 · strength 0.21
- Jiejie Qin · 1 shared paper, 2024 · strength 0.15
- Shuyu Zhai · 1 shared paper, 2024 · strength 0.15
- Yihao Liu · 1 shared paper, 2024 · strength 0.15
- Weishen Wang · 1 shared paper, 2024 · strength 0.15
- Dongfeng Cheng · 1 shared paper, 2024 · strength 0.15
- Xiaxing Deng · 1 shared paper, 2024 · strength 0.15
- Youwei Zhu · 1 shared paper, 2024 · strength 0.15
- Yang Liu · 1 shared paper, 2024 · strength 0.15
- Chenlei Wen · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.